These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 35474035)

  • 41. A Review of Genetic Abnormalities in Unicentric and Multicentric Castleman Disease.
    Butzmann A; Kumar J; Sridhar K; Gollapudi S; Ohgami RS
    Biology (Basel); 2021 Mar; 10(4):. PubMed ID: 33804823
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hyaline vascular variant of unicentric Castleman disease of the tonsil: a case report.
    Li P; Liu H; Li H; Li A; Yu G; Yin W
    Diagn Pathol; 2019 Jun; 14(1):70. PubMed ID: 31253137
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel approach for characterization of KSHV-associated multicentric Castleman disease from effusions.
    Zhou T; Yuan CM; Lurain K; Rous C; Weaver L; Raffeld M; Stetler-Stevenson M; Uldrick TS; Filie AC; Pittaluga S; Jaffe ES; Marshall V; Moore K; Whitby D; Ramaswami R; Yarchoan R; Wang HW
    Br J Haematol; 2023 Feb; 200(4):462-475. PubMed ID: 36264007
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Castleman disease and TAFRO syndrome: To improve the diagnostic consciousness is the key.
    Zhou QY
    World J Clin Cases; 2022 Feb; 10(5):1536-1547. PubMed ID: 35211591
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinicopathological comparison and therapeutic approach to Castleman disease-a case-based review.
    Wojtyś M; Piekarska A; Kunc M; Ptaszyński K; Biernat W; Zaucha JM; Waloszczyk P; Lisowski P; Kubisa B; Grodzki T
    J Thorac Dis; 2019 Nov; 11(11):4859-4874. PubMed ID: 31903277
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Multicentric Castlemans disease. Symptoms, diagnostics and therapy].
    Adam Z; Řehák Z; Adamová Z; Koukalová R; Pour L; Krejčí M; Boichuk I; Sandecká V; Krejčí M; Štork M; Ševčíková S; Král Z
    Vnitr Lek; 2022; 68(1):41-53. PubMed ID: 35459346
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of interleukin 6 in the pathogenesis and therapy of Castleman disease - an immunologist's perspective.
    Milota T; Střížová Z; Sobotková M; Bartůňková J
    Cas Lek Cesk; 2023; 162(2-3):106-111. PubMed ID: 37474295
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multicentric Castleman disease of hyaline vascular variant presenting with unusual systemic manifestations: a case report.
    Basnayake BMDB; Wazil AWM; Kannangara T; Ratnatunga NVI; Hewamana S; Ameer AM
    J Med Case Rep; 2017 May; 11(1):135. PubMed ID: 28501028
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Rare Lymphoproliferative Disease: Castleman Disease.
    Gündüz E; Özdemir N; Bakanay ŞM; Karakuş S
    Turk J Haematol; 2021 Dec; 38(4):314-320. PubMed ID: 34719151
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Overlapping polyclonal lymphoproliferative disorders.
    Bonometti R; Bellan M; Sola D; Gibbin A; Gavelli F; Patrucco F; Spina P; Gualerzi A; Favretto S; Castello LM; Sainaghi PP; Pirisi M
    Natl Med J India; 2020; 33(6):344-346. PubMed ID: 34341211
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease?
    Fujimoto S; Sakai T; Kawabata H; Kurose N; Yamada S; Takai K; Aoki S; Kuroda J; Ide M; Setoguchi K; Tsukamoto N; Iwao-Kawanami H; Kawanami T; Mizuta S; Fukushima T; Masaki Y
    Am J Hematol; 2019 Sep; 94(9):975-983. PubMed ID: 31222819
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bone marrow findings of idiopathic Multicentric Castleman disease: A histopathologic analysis and systematic literature review.
    Belyaeva E; Rubenstein A; Pierson SK; Dalldorf D; Frank D; Lim MS; Fajgenbaum DC
    Hematol Oncol; 2022 Apr; 40(2):191-201. PubMed ID: 35104370
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Castleman disease].
    Meignin V; Calvani J; Oksenhendler E
    Ann Pathol; 2023 Jan; 43(1):13-24. PubMed ID: 36192235
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Castleman Disease.
    Wang W; Medeiros LJ
    Surg Pathol Clin; 2019 Sep; 12(3):849-863. PubMed ID: 31352991
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease.
    Fajgenbaum DC
    Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):318-325. PubMed ID: 30504327
    [TBL] [Abstract][Full Text] [Related]  

  • 56. TAFRO syndrome: current perspectives.
    Sakashita K; Murata K; Takamori M
    J Blood Med; 2018; 9():15-23. PubMed ID: 29403325
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Unicentric Castleman disease: A case report of an atypical presentation and successful management.
    Muhammad T; Alkheder A; Mazloum A; Almooay A; Naziha L; Shaheen M
    Int J Surg Case Rep; 2024 May; 118():109688. PubMed ID: 38669805
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV-MCD) and the KSHV Inflammatory Cytokine Syndrome.
    Polizzotto MN; Uldrick TS; Hu D; Yarchoan R
    Front Microbiol; 2012; 3():73. PubMed ID: 22403576
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The management of Castleman disease.
    Lomas OC; Streetly M; Pratt G; Cavet J; Royston D; Schey S; Ramasamy K;
    Br J Haematol; 2021 Nov; 195(3):328-337. PubMed ID: 34340261
    [No Abstract]   [Full Text] [Related]  

  • 60. [Analysis of the clinicopathologic features as well as diagnosis and treatment of 59 patients with Castleman disease].
    Wang J; Liang LJ; Wang YM; Mei ZY; Liu YZ; Liu LN; Fang BJ; Song YP
    Zhonghua Xue Ye Xue Za Zhi; 2020 Aug; 41(8):666-670. PubMed ID: 32942821
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.